Carisma Therapeutics, Inc. CARM
Set alert
0.00 USD 0.00 -28.57%
At close · Oct 30
0.12 +0.12 +23,520.00%
After hours · Oct 30, 4:00 PM ET
0.0263 Day range 0.0324
0.0001 52-week range 0.10
- YTD
- -98.84%
- 1 year
- -99.11%
- Open
- 0.02725
- Prev close
- 0.0007
- Mkt cap
- 20.92K
- Vol
- 10.30K
- Avg vol
- 31.70K
- EPS
- 0.19
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0263
- High
- 0.0324
- Forward P/E
- -0.43
- Beta
- 0.00
- Short ratio
- 2.88
- Inst. own
- 31.47%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.85396
- 200-d avg
- 1.25
- 1y target
- 4.57
Analyst view
Consensus: hold
Hold
Price target (mean) 4.57 +913234.0% upside
Now 0.0005
- Target (low)
- 0.70
- Target (mean)
- 4.57
- Target (high)
- 12.00
Ratings (0m) 5 1 buy · 4 hold · 0 sell
- Strong buy0
- Buy1
- Hold4
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 5
- 2 months ago 6
- 3 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.19 | -0.28 – -0.13 | -0.48 | +60.4% | 5.42M | +26.4% | 3 |
| Next quarter | -0.18 | -0.28 – -0.08 | -0.46 | +60.9% | 4.69M | +38.1% | 2 |
| Current year | -1.23 | -1.32 – -1.16 | -2.59 | +52.6% | 21.41M | +43.5% | 3 |
| Next year | -0.53667 | -1.00 – -0.29 | -1.23 | +56.3% | 20.32M | -5.1% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 16, 2024 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Dec 12, 2024 | D. Boral Capital | Maintained | Buy | Buy |
| Dec 12, 2024 | Baird | Downgrade | Outperform | Neutral |
| Dec 11, 2024 | Evercore ISI Group | Downgrade | Outperform | In-Line |
| Dec 10, 2024 | BTIG | Downgrade | Buy | Neutral |
| Dec 9, 2024 | D. Boral Capital | Maintained | Buy | Buy |
| Nov 25, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 18, 2024 | D. Boral Capital | Maintained | Buy | Buy |
| Nov 11, 2024 | D. Boral Capital | Maintained | Buy | Buy |
| Nov 7, 2024 | EF Hutton | Maintained | Buy | Buy |
| Oct 30, 2024 | EF Hutton | Initiated | — | Buy |
| Jun 28, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 26, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 17, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 10, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Apr 11, 2024 | BTIG | Initiated | — | Buy |
| Apr 2, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 29, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 3, 2023 | Capital One | Initiated | — | Overweight |
| Sep 6, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 11, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 6, 2023 | Evercore ISI Group | Initiated | — | Outperform |
| Jun 29, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 28, 2023 | Baird | Reiterated | Outperform | Outperform |
| May 24, 2023 | HC Wainwright & Co. | Initiated | — | Buy |
| Apr 14, 2023 | Baird | Initiated | — | Outperform |